bacterial infections

Researchers integrated results from a pathogen-host association study with available clinical data to find variants influencing both infection responses and other disease risks.

Vela purchased Great Basin for $1.4 million in June, and will reopen its Utah-based lab, rehire employees, and commercialize the firm's infectious disease platform.

The acquisition nets Vela a US manufacturing and R&D site, as well as Great Basin's multiplexing platform and six existing FDA-approved products.

Cornell researchers plan to test cell-free DNA in a prospective study for diagnosing infection and antimicrobial resistance in kidney transplant patients.

The French firm will assess the ability of its iDtect metagenomic NGS assay to identify pathogenic bacteria and viruses in febrile neutropenia patients.

The funding will help Mobidiag scale up production of its Novodiag instruments and disposable cartridges, and improve its global sales and marketing activities.

The award will go toward the development of MicrobeDx's technology for detecting the presence of bacteria in clinical urine specimens and to which antibiotics they are susceptible.

Jean-Laurent Casanova aims to identify single-gene mutations that compromise the immunity of normally healthy individuals and lead to severe infectious disease.

The firm offers two clinical assays, and is in discussions with Qiagen about developing its assays for the GeneReader.

The firm uses at least five types of metagenomic assays to detect the relative abundance of microbial species in the oral and pulmonary microbiomes.

Pages

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.